The Effectiveness of an Oral Fixed-Dose Combination of Netupitant and Palonosetron (NEPA) in Patients With Multiple Risk Factors for Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Observational Indian Study

Background Female gender, young age, first chemotherapy cycle, and low alcohol intake have all been linked to an increased risk of nausea and vomiting from chemotherapy. We intended to see if netupitant and palonosetron (NEPA) could prevent chemotherapy-induced nausea and vomiting (CINV) in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaswani, Bharat, Dattatreya, Palanki S, Barkate, Hanmant, Bhagat, Sagar B, Patil, Saiprasad, Jadhav, Amit Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573141/
https://www.ncbi.nlm.nih.gov/pubmed/36259011
http://dx.doi.org/10.7759/cureus.29094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573141/
https://www.ncbi.nlm.nih.gov/pubmed/36259011
http://dx.doi.org/10.7759/cureus.29094

Ejemplares similares